Advances in melanoma senescence and potential clinical application - Archive ouverte HAL Access content directly
Journal Articles Pigment Cell & melanoma research Year : 2011

Advances in melanoma senescence and potential clinical application

Advances in melanoma senescence and potential clinical application

(1) , (1) , (1, 2) , (1, 2)
1
2

Abstract

Normal cells possess a limited proliferative life span, after which they enter a state of irreversible growth arrest, called replicative senescence, which acts as a potent barrier against transformation. Transformed cells have escaped the process of replicative senescence and theoretically can not re-enter senescence. However, recent observations showed that transformed cells, and particularly the melanoma cells, can still undergo oncogene or stress-induced senescence. This senescence state is accompanied by many of the markers associated with replicative senescence, such as flattened shape, increased acidic β-galactosidase activity, characteristic changes in gene expression and growth arrest. Interestingly, in some cancers, senescence induction following chemotherapy has been correlated with a favorable patient outcome. In this review, we gathered recent results describing senescence-like phenotype induction in melanoma cells and discuss why senescence may also be exploited as a therapeutic strategy in melanoma.

Keywords

Fichier principal
Vignette du fichier
Bertolotto PCMR 2011.pdf (510.72 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

inserm-02530650 , version 1 (07-04-2020)

Identifiers

Cite

Sandy Giuliano, Mickaël Ohanna, Robert Ballotti, Corine Bertolotto. Advances in melanoma senescence and potential clinical application. Pigment Cell & melanoma research, 2011, 24 (2), pp.295-308. ⟨10.1111/j.1755-148X.2010.00820.x⟩. ⟨inserm-02530650⟩
40 View
122 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More